2025
Dr. Peter Kash
Co-founder and Vice Chairman of the Board of iOncologi, he leads an international effort that is transforming the treatment of glioblastoma and pediatric osteosarcoma—two of the most aggressive cancers in children. After more than a decade of research, iOncologi now has two platforms in human clinical trials and plans to expand its studies to Mexico and Argentina, in addition to its current collaborations in Florida (USA) and the Sheba Medical Center in Israel.
Its model integrates next-generation immunotherapies, precision delivery, and artificial intelligence, aiming to overcome historical barriers such as tumor heterogeneity and the blood–brain barrier, paving the way for universal and personalized therapies against incurable solid tumors. Beyond his scientific impact, Dr. Kash also stands out for his philanthropic commitment: his book “Take Two Tablets: Medicine From the Bible,” recently translated into Spanish as “La Medicina en la Biblia,” donates 100% of its royalties to purchasing Sony PlayStations that are given to hospitals in South America, Mexico, and Spain to improve the quality of life of children with cancer. This project brings together cutting-edge science with empathy and social responsibility, showing how innovation can transform both health and the hope of thousands of families.
2024
BIOGRIP TECH
Wireless nerve-machine interface that connects Echos robo systems to the human body. With just a thought, the device learns to perform natural, simultaneous, and complex movements.
2023
Griyum
They produce ingredients with maximum nutrients and minimal environmental impact using edible crickets cultivated in rural communities. These ingredients are easy to integrate into recipes and formulations for bakery products, cookies, tortillas, supplements, and meat analogs.
2022
Dr. Vagón
The Health Train consists of 17 carriages and an operating room, enabling the provision of laboratory tests, general and specialized medical consultations, family planning services, and a specialized clinic for comprehensive women’s health and diabetic patients. This setup allows for the delivery of FREE, high-quality medical services.
2021
Eviter
Gresmex, a Mexican company with over 20 years of international presence, has developed a unique nanobiomolecule, patented in over 100 countries. This molecule offers several key benefits: it acts directly on the DNA or RNA of viruses, bacteria, fungi, spores, and mycobacteria, preventing the development of resistance. It is non-corrosive, non-cytotoxic, 100% harmless, and biodegradable. Its safety and efficacy have been confirmed by multiple laboratories in Mexico and around the world.
2020
Campaña de Salud
Hepática
Clara Lau, General Director of Biomédica de Referencia and President of COMED (the Mexican Council of Diagnostic Companies), an organization that brings together the largest and most prestigious laboratories and diagnostic centers in the country, has spearheaded the initiative to define and establish biosafety protocols. These protocols are crucial for ensuring the correct collection and handling of biological samples, as well as for setting guidelines.
